The frequency of clinical pregnancy and implantation rate after cultivation of embryos in a medium with granulocyte macrophage colony-stimulating factor (GM-CSF) in patients with preceding failed attempts of ART

Gynecological Endocrinology

Volumn 30, Issue , 2014, Pages 9-12

  Tevkin, S ^a   Lokshin, V ^a   Shishimorova, M ^a   Polumiskov, V ^a  

^a EKO Centre   (Kazakhstan)

Author keywords

Cytokines; Embryo culture; GM CSF; Implantation; in vitro fertilization

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; CULTURE MEDIUM; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMPLANTATION; IN VIVO STUDY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PLACENTA; PREGNANCY OUTCOME; PREGNANCY RATE; TREATMENT FAILURE; DRUG EFFECTS; MALE; NIDATION; PHARMACOLOGY; PHYSIOLOGY; PREGNANCY; PROCEDURES; STANDARDS;

ADULT; CULTURE MEDIA; EMBRYO CULTURE TECHNIQUES; EMBRYO IMPLANTATION; EMBRYONIC DEVELOPMENT; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84907056512     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.945767     Document Type: Article

References (35)

1. Radzinsky VE, Dimitrov VI, Miskova M. EU non-developing pregnancy. GEOTAR-Media 2009:200.
2. Sidelnikov VM, Sucyich GT. Miscarriage: a guide for practitioners. MIA 2010:536.
3. Sudoma IA, Masliy JV. Algorithm of examination and treatment of patients with multiple unsuccessful art programmes. The materials of the XVII international conference "Reproductive technology today and tomorrow"; 2007; Kazan. pp. 20-21.
4. Coulam CB, Acacio B. Does immunotherapy for treatment of reproductive failure enhance live births? Am J Reprod Immunol 2012;67:296-304.
5. D'Hooghe TM, Denys B, Spiessens C, et al. Is the endometriosis recurrence rate increased after ovarian hyperstimulation? Fertil Steril 2006;86:283-90.
6. Levi-Setti PE, Colombo GV, Savasi V. Implantation failure in assisted reproduction technology and a critical approach to treatment. Ann NY Acad Sci 2004;1034:184-99.
7. Seidov LA, Yavoriv KA. Paracrine regulators implantation (literature review). Probl Reprod 2010;3:7-10.
8. Donaghay M, Lessey BA. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med 2007;25: 461-75.
9. Segerer S, Kämmerer U, Kapp M, et al. Upregulation of chemokine and cytokine production during pregnancy. Gynecol Obstetr Invest 2009;67:145-50.
10. Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online 2006;13:13-23.
11. Robertson SA. GM-CSF regulation of embryo development and pregnancy. Cytokine Growth Factor Rev 2007;18:287-98.
12. Scarpellini F, Sbracia M. Effectiveness of GM-CSF 1 in the treatment of habitual abortion in a controlled study. Fertil Steril 2003;80:288.
13. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomized controlled trial. Human Reprod 2009;24:2703-8.
14. Roth I, Corry DB, Locksley RM, et al. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996;184:539-48.
15. Laird SM, Tuckerman EM, Cork BA, et al. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003;9:163-74.
16. Makhseed M, Raghupathy R, Azizieh F, et al. Th1 and Th2 cytokine profiles in recurrent abortus with successful pregnancy and with subsequent abortions. Hum Reprod 2001;16:2219-26.
17. Dumoulin JC, Land JA, Van Montfoort EC, et al. Effect of in vitro culture of human embryos on birth weight of newborns. Hum Reprod 2010;25:605-12.
18. Hardy K, Handysid AH, Winston RML. The human blastocyst: cell number, death and allocation during late preimplantation development in vitro. Development 1989;107:597-604.
19. Hansen M, Kurinczuk J, Bower C, et al. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002;346:725-30.
20. Maher RM, Brueton LA, Bowdin SC, et al. Epigenetic risks related to assisted reproductive technologies: epigenetics, imprinting, ART and icebergs? Hum Reprod 2003;18:2508-11.
21. Imakawa K, Carlson KD, McGuire WJ, et al. Enhancement of ovine trophoblast interferon by granulocyte macrophage-colony stimulating factor: possible involvement of protein kinase C. J Molec Endocrinol 1997;19:121-30.
22. Robertson SA. GM-CSF regulation of embryo development and pregnancy. Cytokine Growth Factor Rev 2007;18:287-98.
23. Sfontouris IA, Lainas GT, Anagnostara K, et al. Effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on pregnancy rates in patients with multiple unsuccessful IVF attempts. Hum Reprod 2013;28:62.
24. Sjoblom C, Wikland M, Robertson SA. Granulocyte macrophage colony-stimulating factor promotes human blastocyst development in vitro. Hum Reprod 1999;14:3069-76.
25. Sjoblom C, Roberts CT, Wikland M, et al. Granulocyte-macrophage colony-stimulating factor alleviates adverse consequences of embryo culture on fetal growth trajectory and placental morphogenesis. Endocrinology 2005;146:2142-53.
26. Kim D, Kim M, Kang H, et al. The supplementation of granulocytemacrophage colony-stimulating factor (GM-CSF) in culture medium improves the pregnancy rate in human ART programs. Fertil Steril 2001;76:S6.
27. Sharkey AM, Robertson SA. Sperm and seminal plasma differentially regulate cytockine and chemokine protein expression by human cervical epithelial cells. J Reprod Immunol 2010;86:68.
28. Perricone R, De Carolis C, Giacomelli R, et al. GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. Am J Reprod Immunol 2003;50:232-7.
29. Renzini MM, Dal Canto M, Coticchio G, et al. Clinical efficiency and perinatal outcome of ART cycles following embryo culture in the presence of GM-CSF in patients with miscarriage or early pregnancy loss history. Hum Reprod 2013;28:142.
30. Ziebe S, Loft A, Povlsen BB, et al. A randomized clinical trial to evaluate the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) in embryo culture medium for in vitro fertilization. Fertil Steril 2013;99:1600-9.
31. Elaimi A, Harper JC. The use of time-lapse imaging and FISH to study the effect of GM-CSF on development and aneuploidy in murine blastocysts. Hum Reprod 2012;27:162-205.
32. Plokhinsky NA. Biometrics. Novosibirsk: The Academy of Sciences of the USSR; 1961.
33. Lim KJ, et al. The role of T-helper cytokines in human reproduction. Fertil Steril 2000;73:136-42.
34. Kostromina NU, Gordeeva VL, Monakhov IV, Zdanovsky VM. Application environment EmbryoGen for cultivation of oocytes and embryos. Materials of the XXIII international conference "Reproductive technology today and tomorrow" 2013; Volgograd; pp. 53-4.
35. Richter KS. The importance of growth factors for preimplantation embryo development and in-vitro culture. Curr Opin Obstetr Gynecol 2008;20:292-304.